Acidum valproicum/natrii valproas
| Authors | |
|---|---|
| Year of publication | 2006 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | valproic acid; valproate sodium; epilepsy; bipolar depression; migraine prevention |
| Description | Valproic acid and valproate sodium are substances with anticolvulsive effect to broad spectrum of epileptic seizures including partial and generalised seizures as well as special epileptic syndromes. These compounds are also approved for the treatment af manic phases of bipolar depression and prevention of migraine attacks. For the broad spectrum of effects are responsile various mechanism of action an the neurotransmitter level, their second messengers, transcription factors and gene expression. These substances are rapidly absorbed, metabolised in the liver and bound to plasma proteins. Elimination is mainly into the urine, half life varies between 8-20 hours. Hepatotoxicity and teratogenicity can lead to the serious complications during the treatment. There is no induction of hepatic enzymes. The dose is individually titrated, normaly ranges between 20-30,g/kg/day. |
| Related projects: |